SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (647)1/19/2005 12:38:09 PM
From: Jibacoa  Respond to of 3722
 
And in that stem cell field, AVII is up 85% after it announced it received two patents covering the use of antisense to modulate stem cell maturation.

AVII antisense agents target transforming TGF-beta and other gene targets and have been shown to program stem cells in culture for long-term survival after implantation.

biz.yahoo.com

AVII is trading above the resistance from its May 2004 H of 3.70 and its April 2004 H at 3.74 as well as its March 2004 H of 3.88 <g>

bigcharts.marketwatch.com

The next important resistance seems now to be the Sep.2003 H at 6.24 and the June 2003 H at 7.48 It is still long way from its Feb.2000 H at 27.25 <g>

bigcharts.marketwatch.com

Bernard